SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-260628
Filing Date
2022-10-11
Accepted
2022-10-11 16:15:56
Documents
12
Period of Report
2022-09-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d385667d8k.htm   iXBRL 8-K 25318
  Complete submission text file 0001193125-22-260628.txt   150330

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220930.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220930_lab.xml EX-101.LAB 18740
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220930_pre.xml EX-101.PRE 11714
6 EXTRACTED XBRL INSTANCE DOCUMENT d385667d8k_htm.xml XML 3513
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 221304248
SIC: 2834 Pharmaceutical Preparations